Lemaitre Vascular (LMAT) Retained Earnings (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Retained Earnings came in at $194.7 million in Q1 2026, up 3878.05% year-on-year from $4.9 million in Q1 2025, and up 5.4% on a QoQ basis from $184.7 million in Q4 2025.
Lemaitre Vascular (LMAT) Retained Earnings (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Retained Earnings data on file, last reported at $194.7 million in Q1 2026.
- On a quarterly basis, Retained Earnings rose 3878.05% year-over-year to $194.7 million in Q1 2026; TTM through Mar 2026 was $194.7 million, a 3878.05% increase from a year earlier, with the FY2025 full-year figure at $184.7 million, up 27.31% from the prior year.
- Retained Earnings for Q1 2026 stood at $194.7 million, up from $184.7 million in the prior quarter.
- Over the last five years, Retained Earnings for LMAT reached as high as $194.7 million in Q1 2026 and fell as low as -$8.1 million in Q3 2022.
- Historically, Retained Earnings has averaged $75.9 million across 5 years, with a median of $97.8 million in 2022.
- Across the five-year window, Retained Earnings plunged 208.31% in 2022 and soared 3878.05% in 2026, its largest moves.
- Year by year, Retained Earnings stood at $97.8 million in 2022, then increased by 18.06% to $115.4 million in 2023, then increased by 25.7% to $145.1 million in 2024, then increased by 27.31% to $184.7 million in 2025, then climbed by 5.4% to $194.7 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $194.7 million in Q1 2026, $184.7 million in Q4 2025, and -$2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 22.11 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1.76 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 122.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -24.91 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.98 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 1.81 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.55 Bn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | 194.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194.68 Mn |
| Dec 31, 2025 | 184.72 Mn |
| Sep 30, 2025 | -2.91 Mn |
| Jun 30, 2025 | 160.84 Mn |
| Mar 31, 2025 | -5.15 Mn |
| Dec 31, 2024 | 145.09 Mn |
| Sep 30, 2024 | -3.16 Mn |
| Jun 30, 2024 | -5.09 Mn |
| Mar 31, 2024 | 121.73 Mn |
| Dec 31, 2023 | 115.43 Mn |
| Sep 30, 2023 | 110.08 Mn |
| Jun 30, 2023 | 105.70 Mn |
| Mar 31, 2023 | -5.57 Mn |
| Dec 31, 2022 | 97.77 Mn |
| Sep 30, 2022 | -8.13 Mn |
| Jun 30, 2022 | -6.44 Mn |
| Mar 31, 2022 | 91.42 Mn |
| Dec 31, 2021 | -3.44 Mn |
| Sep 30, 2021 | -2.64 Mn |
| Jun 30, 2021 | 80.25 Mn |